• LAST PRICE
    14.3000
  • TODAY'S CHANGE (%)
    Trending Up0.3000 (2.1429%)
  • Bid / Lots
    14.2900/ 3
  • Ask / Lots
    14.3100/ 4
  • Open / Previous Close
    13.9200 / 14.0000
  • Day Range
    Low 13.6100
    High 14.3200
  • 52 Week Range
    Low 10.1200
    High 39.1100
  • Volume
    172,669
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 14
TimeVolumeBHC
09:32 ET870013.78
09:34 ET630013.65
09:36 ET460013.68
09:38 ET410013.73
09:39 ET660013.79
09:41 ET400013.8
09:43 ET1030013.93
09:45 ET960013.9
09:48 ET1050013.89
09:50 ET1000013.91
09:52 ET370013.93
09:54 ET660014.04
09:56 ET300014.05
09:57 ET1080013.95
09:59 ET440013.94
10:01 ET810013.94
10:03 ET530014.02
10:06 ET820014.03
10:08 ET750014.05
10:10 ET1410014.22
10:12 ET550014.2
10:14 ET250014.23
10:15 ET460014.26
10:17 ET980014.31
10:19 ET400014.3
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
CanadaBHC
Bausch Health Companies Inc
4.8B
-9.7x
---
CanadaGTII
Green Thumb Industries Inc
3.1B
32.2x
---
CanadaCL
Cresco Labs Inc
1.5B
-3.3x
---
CanadaCCHW
Columbia Care Inc
1.0B
-4.5x
---
CanadaAAWH.U
Ascend Wellness Holdings Inc
528.8M
-3.5x
---
CanadaAYR.A
Ayr Wellness Inc
366.9M
-13.7x
---
As of 2022-05-16

Company Information

Bausch Health Companies Inc. is a specialty pharmaceutical and medical device company. The Company is engaged in developing, manufacturing, and marketing a range of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products, and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment and aesthetics devices), which are marketed directly or indirectly in over 100 countries. Its segments include Bausch + Lomb, Salix, Ortho Dermatologics, International Rx and Diversified Products. The Bausch + Lomb segment consists of sales in the United States of Bausch + Lomb Vision Care, Consumer, Surgical and Ophthalmology Rx products. The Salix segment consists of sales in the United States of gastroenterology (GI) products. The Ortho Dermatologics segment consists of sales in the United States of Ortho Dermatologics (dermatological) products and global sales of Solta medical aesthetic devices.

Contact Information

Headquarters
2150 Saint-Elzear Blvd WLAVAL, QC, Canada H7L 4A8
Phone
514-744-6792
Fax
514-744-6792

Executives

Chairman of the Board, Chief Executive Officer
Joseph Papa
Chief Financial Officer, Executive Vice President
Sam Will
President and Co-Head Bausch + Lomb/International
Thomas Appio
President and Co-Head Bausch + Lomb/International
Joseph Gordon
President - Salix
Robert Spurr

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$4.8B
Revenue (TTM)
$10.8B
Shares Outstanding
361.4M
Bausch Health Companies Inc does not pay a dividend.
Beta
1.74
EPS
$-1.48
Book Value
$-0.38
P/E Ratio
-9.7x
Price/Sales (TTM)
0.4
Price/Cash Flow (TTM)
3.3x
Operating Margin
10.80%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.